サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1300988

北米の脱毛症市場規模、シェア、動向分析レポート：治療法別（医薬品、デバイス）、疾患タイプ別（円形脱毛症）、最終用途別、販売チャネル別、性別、国別、セグメント別予測、2023年～2030年

North America Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, Devices), By Disease Type (Alopecia Areata), By End-use, By Sales Channel, By Gender, By Country, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
北米の脱毛症市場規模、シェア、動向分析レポート：治療法別（医薬品、デバイス）、疾患タイプ別（円形脱毛症）、最終用途別、販売チャネル別、性別、国別、セグメント別予測、2023年～2030年
出版日: 2023年06月06日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の脱毛症市場の成長と動向

Grand View Research, Inc.の最新レポートによると、北米の脱毛症市場規模は2023年から2030年にかけてCAGR 7.5％で拡大し、2030年には56億5,000万米ドルに達する見込みです。

同市場は、治療法の技術的進歩、脱毛に関連する疾患の有病率の上昇によって総体的に牽引されると予測されます。さらに、光ベースの治療法やその他の医薬品開発など、大手企業による様々な戦略的イニシアティブも、予測期間中の成長を促進すると予測されています。

北米の脱毛症業界では、有力な市場参入企業が存在するため、競争企業間の敵対関係は高止まりするとみられます。ブランド薬のジェネリックコピーは、商業競争をさらに激化させる。主なプレーヤーは、臨床ニーズが満たされていない人々をターゲットに、新規の治療法や薬剤の開発に携わっています。例えば、Cassiopea S.p.A.は、女性の男性型脱毛症の治療薬の開発に取り組んでいます。

National Alopecia Areata Foundation（NAAF）、Canadian Alopecia Areata Foundation（カナダ円形脱毛症財団）、Cicatricial Alopecia Research Foundation（瘢痕性脱毛症研究財団）などの団体は、治療に関する研究開発や製品開発を支援するための資金提供を推進しています。例えば、National Alopecia Areata Foundation（NAAF）は、研究者に研究助成金と資金を提供しています。現在までに同団体は、疾患の病態生理学、免疫経路、標的治療法の開発に関する研究を支援するために、総額約570万米ドルの研究助成金を208件提供しています。

さらに、毛髪障害研究のギャップを減らすための主要機関による継続的な資金提供プログラムは、市場拡大を促進すると思われます。例えば、2021年4月、米国皮膚科学会は、HAIR（Hair Loss and Alopecia Initiative in Research）資金提供プログラムの開始を発表しました。このHAIRプログラムでは、米国内の研究者、研修生、皮膚科医を対象に、毛髪障害の新規ソリューション開発のための研究プロジェクトを完了するための資金が提供されます。

さらに、規制当局の承認や大手企業による様々な戦略的取り組みが、成長を前進させると予想されています。例えば、2022年6月、Incyte社とEli Lilly and Company社は、OLUMIANT（バリシチニブ）が重度のAA成人に対する全身治療薬として米国FDAから承認を取得したと発表しました。オルミアントは1mg、2mg、4mgの錠剤があります。さらに2020年4月、アイトゥ・バイオサイエンス社はミノキシジルの男女兼用OTCフォーム製剤の発売を発表しました。この製品は脱毛の回復を適応としており、同社の完全子会社であるInnovus Pharmaceuticals社を通じて入手可能です。

北米の脱毛症市場レポートハイライト

  • 治療薬別では、医薬品が広く利用可能であること、新規治療薬が存在することから、医薬品セグメントが北米の脱毛症業界で最大のシェアを占めています。
  • 重症型脱毛症に対する意識の高まりにより、疾患タイプ別では普遍性脱毛症が最も高いCAGRを記録する見込み
  • 最終用途別では、レーザー技術などの最新の治療法の利用可能性と医師や皮膚科医への受診が増加していることから、皮膚科クリニック部門が2022年の北米の脱毛症業界で最大のシェアを占めました。
  • 2022年には男性セグメントが最大のシェアを占めたが、予測期間中は女性セグメントが最も高いCAGRで成長する見込みです。
  • 主な市場企業には、Pfizer Inc、Eli Lilly and Company、Merck & Co., Inc、Concert Pharmaceuticals、Curallux, LLC、PureTech、Freedom Laser Therapy, Inc、LUTRONIC、HCW Biologics Inc、Curallux, LLCなどがあります。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
    • セグメントの定義
    • セグメントと地域の範囲
    • 推定・予測のタイムライン
  • 調査手法
  • 情報調達
    • 購入したデータベース：
    • Gvrの内部データベース
    • 二次情報
    • 1次調査
    • 1次調査の詳細
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の形成と検証
  • モデル詳細
    • 商品フロー分析
  • 調査の仮定
  • 二次情報のリスト
  • 略語のリスト
  • 目的

第2章 エグゼクティブサマリー

  • 市場スナップショット
  • セグメントのスナップショット
    • 競合情勢のスナップショット

第3章 北米の脱毛症市場の変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 付随的な市場見通し
  • 普及と成長の見通しのマッピング
  • 規制状況
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 脱毛症：市場分析ツール
    • 業界分析- ポーターズ-（医薬品）
    • 業界分析- ポーターズ（デバイス）
    • SWOT分析、要因別（政治・法律、経済・技術）（医薬品）
    • SWOT分析、要素別（政治・法律、経済・技術）（デバイス）
  • パイプライン分析

第4章 北米の脱毛症市場：セグメント分析、疾患タイプ別、2018年～2030年（100万米ドル）

  • 北米の脱毛症市場：疾患タイプの変動分析
    • 市場規模、予測、傾向分析、2018年から2030年まで
    • 円形脱毛症
    • 瘢痕性脱毛症
    • 牽引性脱毛症
    • 全頭脱毛症
    • 汎発性脱毛症
    • 男性型脱毛症
    • その他

第5章 北米の脱毛症市場：セグメント分析、治療法別、2018年～2030年（100万米ドル）

  • 北米の脱毛症市場：治療変動分析
  • 2018年から2030年の市場規模、予測、傾向分析
    • 医薬品
    • デバイス

第6章 北米の脱毛症市場：セグメント分析、性別、2018年～2030年（100万米ドル）

  • 北米の脱毛症市場：ジェンダー変動分析
  • 市場規模、予測、傾向分析、2018年から2030年まで
    • 男性
    • 女性

第7章 北米の脱毛症市場：セグメント分析、最終用途別、2018年～2030年（100万米ドル）

  • 北米の脱毛症市場：最終用途の変動分析
  • 市場規模、予測、傾向分析、2018年から2030年まで
    • ホームケア設定
    • 皮膚科クリニック

第8章 北米の脱毛症市場：セグメント分析、地域別、2018年～2030年（100万米ドル）

  • 脱毛症市場：国別変動分析
  • 地域市場シェア分析、2022年および2030年
  • 市場規模、予測、収益および傾向分析、2018年から2030年まで
    • 北米

第9章 北米の脱毛症市場：競合分析（医薬品）

  • 主要市場参入企業による最近の動向と影響分析
    • 新製品の発売
    • 合併と買収
    • 合弁事業
    • パートナーシップとライセンス契約
    • カンファレンスとキャンペーン
  • 会社の分類
    • イノベーター
    • 市場リーダー
    • ヒートマップ分析
  • ベンダー情勢
    • List Of Key Distributors And Channel Partners
    • Key Customers
  • 公開会社
    • 主要企業の市場シェア分析、2022年
    • 企業の市況分析
    • 競合ダッシュボード分析
  • 非公開会社
    • 主要な新興企業のリスト
  • 企業プロファイル（医薬品）
    • CIPLA LIMITED
    • SUN PHARMACEUTICALS INDUSTRIES LTD.
    • JOHNSON &JOHNSON SERVICES, INC.
    • MERCK &CO., INC.
    • LEXINGTON INTL., LLC
    • CIRRUS HAIR CENTERS
    • VITA-COS-MED KLETT-LOCH GMBH
    • TRANSITIONS HAIR
    • PURETECH HEALTH
    • CURALLUX, LLC
    • DR. REDDY'S LABORATORIES LTD
    • GLAXOSMITHKLINE PLC（GSK）
    • AUROBINDO PHARMA
    • MYLAN NV（VIATRIS, INC.）

第10章 北米の脱毛症市場：競合分析（デバイス）

  • 主要市場参入企業による最近の動向と影響分析
    • 主要取引と戦略的提携の分析
  • 会社の分類
    • イノベーター
    • 市場リーダー
    • ヒートマップ分析
  • ベンダー情勢
    • 主要な販売代理店とチャネルパートナーのリスト
    • 主要顧客
  • 公開会社
    • 競合ダッシュボード分析
    • 企業市場シェア分析（デバイス）、2022年
  • 非公開会社
    • 主要な新興企業のリスト
  • 企業プロファイル（デバイス）
    • FREEDOM LASER THERAPY, INC.
    • APIRA SCIENCE, INC.（IGROW LASER.）
    • REVIAN, INC
    • THERADOME INC.
    • LUTRONIC INC.
    • WON TECH CO., LTD
    • LIFEMD
    • LG ELECTRONICS
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Regulatory framework
  • Table 4 List of late-stage clinical trials
  • Table 5 Approved generic version of Avodart:
  • Table 6 Androgenetic alopecia in men and women
  • Table 7 List of parameters
  • Table 8 Leading market players anticipated to witness highest growth
  • Table 9 List of key distributors
  • Table 10 Key company market share (%)
  • Table 11 List of parameters
  • Table 12 Leading market players anticipated to witness highest growth
  • Table 13 List of other distributors
  • Table 14 Key company market share (%)
  • Table 15 North America Alopecia Market, By Country, 2018 - 2030 (USD Million)
  • Table 16 North America Alopecia Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 17 North America Alopecia Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 18 North America Alopecia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 19 North America Alopecia Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 20 North America Alopecia Market, By Gender, 2018 - 2030 (USD Million)
  • Table 21 U.S. Alopecia Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 22 U.S. Alopecia Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 23 U.S. Alopecia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 24 U.S. Alopecia Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 25 U.S. Alopecia Market, By Gender, 2018 - 2030 (USD Million)
  • Table 26 Canada Alopecia Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 27 Canada Alopecia Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 28 Canada Alopecia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 29 Canada Alopecia Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 30 Canada Alopecia Market, By Gender, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 North America alopecia market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Primary interviews, by type
  • Fig. 6 Primary interviews, by country
  • Fig. 7 Market research approaches
  • Fig. 8 Value - chain - based sizing & forecasting
  • Fig. 9 QFD modeling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Market outlook (2022)
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Market restraint relevance analysis (Current & future impact)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Porter's five forces analysis, Devices
  • Fig. 17 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 18 SWOT analysis, by factor (political & legal, economic, and technological), Devices
  • Fig. 19 North America alopecia market disease type outlook: Key takeaways
  • Fig. 20 North America alopecia market: Disease type movement analysis
  • Fig. 21 Alopecia areata market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Male alopecia areata market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Female alopecia areata market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Cicatricial alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Male cicatricial alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Female cicatricial alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Traction alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Male traction alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Female traction alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Alopecia totalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Male alopecia totalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Female alopecia totalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Alopecia universalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Male alopecia universalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Female alopecia universalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Male androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Female androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Male other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Female other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 North America Alopecia market treatment outlook: Key Takeaways
  • Fig. 43 Alopecia market: Treatment movement analysis
  • Fig. 44 Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Topical drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Topical OTC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Minoxidil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Topical prescription drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Betamethasone dipropionate market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Fluocinolone acetonide market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Finasteride market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Minoxidil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Oral drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Oral OTC drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Oral prescription drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Minoxidil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Finasteride market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Oral corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Platelet - rich plasma market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Laser cap market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Laser comb market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Laser helmet market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 North America Alopecia market gender outlook: Key takeaways
  • Fig. 66 North America Alopecia market: Gender movement analysis
  • Fig. 67 Male market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Female market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 North America Alopecia market end - use outlook: Key takeaways
  • Fig. 70 North America Alopecia market: end - use movement analysis
  • Fig. 71 Homecare settings market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Dermatology clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 North America Alopecia market sales channel outlook: Key takeaways
  • Fig. 74 North America Alopecia market: Sales channel movement analysis
  • Fig. 75 Prescriptions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 OTC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Regional outlook, 2022 & 2030
  • Fig. 78 North America
  • Fig. 79 North America alopecia market estimates and forecast, 2018 - 2030 (USD Million) (Number of Patients, in Thousands)
  • Fig. 80 U.S.
  • Fig. 81 U.S. alopecia market estimates and forecast, 2018 - 2030 (USD Million) (Number of Patients, in Thousands)
  • Fig. 82 Canada
  • Fig. 83 Canada alopecia market estimates and forecast, 2018 - 2030 (USD Million) (Number of Patients, in Thousands)
  • Fig. 84 Heat map analysis
  • Fig. 85 Company market position analysis (2022)
  • Fig. 86 Company market position analysis (2022)
  • Fig. 87 Market differentiators
  • Fig. 88 Strategy mapping
  • Fig. 89 Heat map analysis
  • Fig. 90 Market differentiators
目次
Product Code: GVR-4-68040-083-4

North America Alopecia Market Growth & Trends

The North America alopecia market size is expected to reach USD 5.65 billion by 2030, expanding at a 7.5% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to be collectively driven by technological advancements in treatments, and the rise in the prevalence of diseases associated with hair loss. Moreover, various strategic initiatives undertaken by leading players such as the development of light-based treatment and other pharmaceutical products developments are also anticipated to propel growth forward during the projected period.

The competitive rivalry in North America alopecia industry is likely to remain high due to the presence of prominent market participants. Generic copies of branded drugs further intensify commercial competition. Key players are involved in the development of novel therapies or drugs, to target people with unmet clinical needs. For instance, Cassiopea S.p.A. is engaged in the development of treatment for female androgenetic alopecia, as there is no drug approved for this particular indication.

Organizations, such as National Alopecia Areata Foundation (NAAF), Canadian Alopecia Areata Foundation, and Cicatricial Alopecia Research Foundation, among others, promote funding to support R&D and product development exercises pertaining to the treatment. For instance, National Alopecia Areata Foundation (NAAF) provides research grants and funding to researchers. To date, the organization has provided 208 research grants, totaling around USD 5.7 million, to sponsor studies on the pathophysiology of diseases, immune pathways, and developing targeted treatments.

Moreover, ongoing funding programs by leading organizations to decrease the gaps in hair disorders research is likely to expedite market expansion. For instance, in April 2021, the American Academy of Dermatology Association announced the launch of the Hair Loss and Alopecia Initiative in Research (HAIR) funding program. Under this HAIR program funding will be offered to researchers, trainees, and dermatologists in the U.S. for completing research projects for the development of novel solutions for hair disorders.

Furthermore, regulatory approvals and various strategic initiatives undertaken by leading players are expected to propel growth forward. For instance, in June 2022, Incyte and Eli Lilly and Company announced that OLUMIANT (baricitinib) received approval from the U.S. FDA for systemic treatment for adults with severe AA. OLUMIANT pill is available in 1 mg, 2 mg, and 4 mg tablets. In addition, in April 2020 Aytu BioScience, Inc. announced the launch of OTC foam formulation of minoxidil for men and women. This product is indicated for reversing hair loss and is available through the company's wholly-owned subsidiary Innovus Pharmaceuticals.

North America Alopecia Market Report Highlights

  • By treatment, the pharmaceutical segment held the largest share of the North America alopecia industry due to the widespread availability of pharmaceutical products, and the presence of novel therapeutics
  • The alopecia universalis segment is expected to register the highest CAGR rate in disease type segment owing to increasing awareness about severe forms of AA
  • By end-use, the dermatology clinics segment held the largest share of the North America alopecia industry in 2022 owing to the availability of modern treatment methods such as laser technology and increasing visits to doctors & dermatologists
  • The male gender segment held the largest share in 2022, whereas, the female gender segment is expected to register the highest CAGR rate during the forecast period
  • Some of the key market players include Pfizer Inc; Eli Lilly and Company; Merck & Co., Inc; Concert Pharmaceuticals; Curallux, LLC; PureTech; Freedom Laser Therapy, Inc; LUTRONIC; HCW Biologics Inc; Curallux, LLC; and others.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Definition
    • 1.1.2 Segment & Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
      • 2.3.Competitive Landscape Snapshot

Chapter 3 North America Alopecia Market Variables, Trends, and Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration And Growth Prospect Mapping
  • 3.3 Regulatory Landscape
  • 3.4 Market Dynamics
    • 3.4.1 Market Driver Analysis
      • 3.4.1.1 Increasing Prevalence Of Alopecia
      • 3.4.1.2 Increasing Healthcare Expenditure
      • 3.4.1.3 Increasing Prevalence Of Chronic Diseases
      • 3.4.1.4 Technological Advancements In Alopecia Treatment
    • 3.4.2 Market Restraint Analysis
      • 3.4.2.1 Lack Of Reimbursement Policies For Alopecia Treatment
      • 3.4.2.2 Increasing Adoption Of Substitutes
  • 3.5 Alopecia: Market Analysis Tools
    • 3.5.1 Industry Analysis - Porter's - (Pharmaceuticals)
    • 3.5.2 Industry Analysis - Porter's (Devices)
    • 3.5.3 Swot Analysis, By Factor (Political & Legal, Economic And Technological) (Pharmaceuticals)
    • 3.5.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological) (Devices)
  • 3.6 Pipeline Analysis

Chapter 4 North America Alopecia Market: Segment Analysis, By Disease Type, 2018 - 2030 (USD Million)

  • 4.1 North America Alopecia Market: Disease Type Movement Analysis
    • 4.1.1 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 4.1.2 Alopecia Areata
      • 4.1.2.1 Alopecia Areata Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.2.2 Male Alopecia Areata Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.2.3 Female Alopecia Areata Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.3 Cicatricial Alopecia
      • 4.1.3.1 Cicatricial Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.3.2 Male Cicatricial Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.3.3 Female Cicatricial Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.4 Traction Alopecia
      • 4.1.4.1 Traction Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.4.2 Male Traction Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.4.3 Female Traction Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.5 Alopecia Totalis
      • 4.1.5.1 List Of Organizations
      • 4.1.5.2 Alopecia Totalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.5.3 Male Alopecia Totalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.5.4 Female Alopecia Totalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.6 Alopecia Universalis
      • 4.1.6.1 Alopecia Universalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.6.2 Male Alopecia Universalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.6.3 Female Alopecia Universalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.7 Androgenetic Alopecia
      • 4.1.7.1 Androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.1.7.2 Male androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.1.7.3 Female androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.1.8 OTHERS
      • 4.1.8.1 Other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.1.8.2 Male other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.1.8.3 Female other alopecia market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 North America Alopecia Market: Segment Analysis, By Treatment, 2018 - 2030 (USD Million)

  • 5.1 North America Alopecia Market: Treatment Movement Analysis
  • 5.2 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.2.1 Pharmaceuticals
      • 5.2.1.1 Pharmaceuticals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2 Topical Drugs
      • 5.2.1.2.1 Topical Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.2 Topical Otc Drugs
      • 5.2.1.2.2.1 Topical Otc Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.2.2 Minoxidil
      • 5.2.1.2.2.2.1 Minoxidil Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.2.3 Other Otc Drugs
      • 5.2.1.2.2.3.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.3 Topical Prescription Drugs
      • 5.2.1.2.3.1 Topical Prescription Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.3.2 Betamethasone Dipropionate
      • 5.2.1.2.3.2.1 Betamethasone Dipropionate Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.3.3 Fluocinolone Acetonide
      • 5.2.1.2.3.3.1 Fluocinolone Acetonide Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.3.4 Finasteride
      • 5.2.1.2.3.4.1 Finasteride Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.3.5 Minoxidil
      • 5.2.1.2.3.5.1 Minoxidil Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3 Oral Drugs
      • 5.2.1.3.1 Oral Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3.2 Oral Otc Drugs
      • 5.2.1.3.2.1 Oral Otc Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3.3 Oral Prescription Drugs
      • 5.2.1.3.3.1 Oral Prescription Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3.3.2 Minoxidil
      • 5.2.1.3.3.2.1 Minoxidil Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3.3.3 Finasteride
      • 5.2.1.3.3.3.1 Finasteride Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3.3.4 Oral Corticosteroids
      • 5.2.1.3.3.4.1 Oral Corticosteroids Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.4 Platelet - Rich Plasma Injections
      • 5.2.1.4.1 Platelet - Rich Plasma Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.2 Devices
      • 5.2.2.1 Devices Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.2.2 Laser Cap
      • 5.2.2.2.1 Laser Cap Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.2.3 Laser Comb
      • 5.2.2.3.1 Laser Comb Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.2.4 Laser Helmet
      • 5.2.2.4.1 Laser Helmet Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 North America Alopecia Market: Segment Analysis, By Gender, 2018 - 2030 (USD Million)

  • 6.1 North America Alopecia Market: Gender Movement Analysis
  • 6.2 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 6.2.1 Male
      • 6.2.1.1 Male Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Female
      • 6.2.2.1 Female Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 North America Alopecia Market: Segment Analysis, By End - Use, 2018 - 2030 (USD Million)

  • 7.1 North America Alopecia Market: End - Use Movement Analysis
  • 7.2 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 7.2.1 Homecare Settings
      • 7.2.1.1 Homecare Settings Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.2 Dermatology Clinics
      • 7.2.2.1 Dermatology Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 North America Alopecia Market: Segment Analysis, By Region, 2018 - 2030 (USD Million) (Number Of Patients, In Thousands)

  • 8.1 Alopecia Market: Country Movement Analysis
  • 8.2 Regional Market Share Analysis, 2022 & 2030
  • 8.3 Market Size, & Forecasts, Revenue And Trend Analysis, 2018 To 2030
    • 8.3.1 North America
      • 8.3.1.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.3.1.2 U.S.
      • 8.3.1.2.1 U.S. Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.3.1.3 Canada
      • 8.3.1.3.1 Canada Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 North America Alopecia Market: Competitive Analysis (Pharmaceuticals)

  • 9.1 Recent Developments And Impact Analysis, By Key Market Participants
    • 9.1.1 New Product Launches
    • 9.1.2 Mergers And Acquisitions
    • 9.1.3 Joint Venture
    • 9.1.4 Partnerships And Licensing Agreements
    • 9.1.5 Conferences And Campaigns
  • 9.2 Company Categorization
    • 9.2.1 Innovators
    • 9.2.2 Market Leaders
    • 9.2.3 Heat Map Analysis
  • 9.3 Vendor Landscape
    • 9.3.1 List Of Key Distributors And Channel Partners
    • 9.3.2 Key Customers
  • 9.4 Public Companies
    • 9.4.1 Key Company Market Share Analysis, 2022
    • 9.4.2 Company Market Position Analysis
    • 9.4.3 Competitive Dashboard Analysis
      • 9.4.3.1 Market Differentiators
  • 9.5 Private Companies
    • 9.5.1 List Of Key Emerging Companies
  • 9.6 Company Profiles (Pharmaceuticals)
    • 9.6.1 CIPLA LIMITED
      • 9.6.1.1 Company overview
      • 9.6.1.2 Financial Performance
      • 9.6.1.3 Product benchmarking
    • 9.6.2 SUN PHARMACEUTICALS INDUSTRIES LTD.
      • 9.6.2.1 Company overview
      • 9.6.2.2 Financial Performance
      • 9.6.2.3 Product benchmarking
      • 9.6.2.4 Strategic initiatives
    • 9.6.3 JOHNSON & JOHNSON SERVICES, INC.
      • 9.6.3.1 Company overview
      • 9.6.3.2 Financial Performance
      • 9.6.3.3 Product benchmarking
      • 9.6.3.4 Strategic initiatives
    • 9.6.4 MERCK & CO., INC.
      • 9.6.4.1 Company overview
      • 9.6.4.2 Financial Performance
      • 9.6.4.3 Product benchmarking
      • 9.6.4.4 Strategic initiatives
    • 9.6.5 LEXINGTON INTL., LLC
      • 9.6.5.1 Company overview
      • 9.6.5.2 Product benchmarking
    • 9.6.6 CIRRUS HAIR CENTERS
      • 9.6.6.1 Company overview
      • 9.6.6.2 Financial Performance
      • 9.6.6.3 Product benchmarking
    • 9.6.7 VITA - COS - MED KLETT - LOCH GMBH
      • 9.6.7.1 Company overview
      • 9.6.7.2 Product benchmarking
    • 9.6.8 TRANSITIONS HAIR
      • 9.6.8.1 Company overview
      • 9.6.8.2 Product benchmarking
    • 9.6.9 PURETECH HEALTH
      • 9.6.9.1 FOLLICA, INC.
      • 9.6.9.1.1 Company overview
      • 9.6.9.2 Financial Performance
      • 9.6.9.3 Product benchmarking
      • 9.6.9.4 Strategic initiatives
    • 9.6.10 CURALLUX, LLC
      • 9.6.10.1 Company overview
      • 9.6.10.2 Product benchmarking
      • 9.6.10.3 Strategic initiatives
    • 9.6.11 DR. REDDY'S LABORATORIES LTD
      • 9.6.11.1 Company overview
      • 9.6.11.2 Financial Performance
      • 9.6.11.3 Product benchmarking
      • 9.6.11.4 Strategic initiatives
    • 9.6.12 GLAXOSMITHKLINE PLC (GSK)
      • 9.6.12.1 Company overview
      • 9.6.12.2 Financial Performance
      • 9.6.12.3 Product benchmarking
    • 9.6.13 AUROBINDO PHARMA
      • 9.6.13.1 Company overview
      • 9.6.13.2 Financial Performance
      • 9.6.13.3 Product benchmarking
    • 9.6.14 MYLAN N.V. (VIATRIS, INC.)
      • 9.6.14.1 Company overview
      • 9.6.14.2 Financial Performance
      • 9.6.14.3 Product benchmarking
      • 9.6.14.4 Strategic initiatives

Chapter 10 North America Alopecia Market: Competitive Analysis (Devices)

  • 10.1 Recent Developments and Impact Analysis, by Key Market Participants
    • 10.1.1 Major Deals And Strategic Alliances Analysis
      • 10.1.1.1 New Product Launches
      • 10.1.1.2 Partnerships and Licensing Agreements
      • 10.1.1.3 Conferences and Campaigns
  • 10.2 Company Categorization
    • 10.2.1 Innovators
    • 10.2.2 Market Leaders
    • 10.2.3 Heat Map Analysis
  • 10.3 Vendor Landscape
    • 10.3.1 List Of Key Distributors And Channel Partners
    • 10.3.2 Key Customers
  • 10.4 Public Companies
    • 10.4.1 Competitive Dashboard Analysis
      • 10.4.1.1 Market Differentiators
    • 10.4.2 Company Market Share Analysis (Devices), 2022
  • 10.5 Private Companies
    • 10.5.1 List Of Key Emerging Companies
  • 10.6 Company Profiles (Devices)
    • 10.6.1 FREEDOM LASER THERAPY, INC.
      • 10.6.1.1 Company overview
      • 10.6.1.2 Product benchmarking
      • 10.6.1.3 Strategic initiatives
    • 10.6.2 APIRA SCIENCE, INC. (IGROW LASER.)
      • 10.6.2.1 Company overview
      • 10.6.2.2 Product benchmarking
      • 10.6.2.3 Strategic initiatives
    • 10.6.3 REVIAN, INC
      • 10.6.3.1 Company overview
      • 10.6.3.2 Product benchmarking
      • 10.6.3.3 Strategic initiatives
    • 10.6.4 THERADOME INC.
      • 10.6.4.1 Company overview
      • 10.6.4.2 Product benchmarking
      • 10.6.4.3 Strategic initiatives
    • 10.6.5 LUTRONIC INC.
      • 10.6.5.1 Company overview
      • 10.6.5.2 Product benchmarking
      • 10.6.5.3 Strategic initiatives
    • 10.6.6 WON TECH CO., LTD
      • 10.6.6.1 Company overview
      • 10.6.6.2 Product benchmarking
      • 10.6.6.3 Strategic initiatives
    • 10.6.7 LIFEMD
      • 10.6.7.1 Company overview
      • 10.6.7.2 Product benchmarking
      • 10.6.7.3 Strategic initiatives
    • 10.6.8 LG ELECTRONICS
      • 10.6.8.1 Company overview
      • 10.6.8.2 Product benchmarking
      • 10.6.8.3 Strategic initiatives